Genomictree Inc
KOSDAQ:228760
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Genomictree Inc
KOSDAQ:228760
|
KR |
|
Australian Goldfields Ltd
OTC:GRXXF
|
CA |
|
Plenti Group Ltd
ASX:PLT
|
AU |
|
S
|
Simco Songda JSC
VN:SDA
|
VN |
|
National Bankshares Inc
F:9F2
|
US |
|
Spire Healthcare Group PLC
LSE:SPI
|
UK |
|
C
|
Constellation Brands Inc
F:CB1A
|
US |
|
C
|
Cardinal Health Inc
XMUN:CLH
|
US |
|
W
|
WEYCO Group Inc
NASDAQ:WEYS
|
US |
|
F
|
Fuelcell Energy Inc
LSE:0A60
|
US |
|
B&M European Value Retail SA
F:BMNU
|
LU |
|
Ross Stores Inc
NASDAQ:ROST
|
US |
|
Rubrik Inc
NYSE:RBRK
|
US |
|
A
|
Assetwise PCL
SET:ASW
|
TH |
|
First Solar Inc
NASDAQ:FSLR
|
US |
|
R
|
Rishabh Digha Steel and Allied Products Ltd
BSE:531539
|
IN |
|
C
|
CaixaBank SA
SWB:48CA
|
ES |
Bankruptcy Probability
Genomictree Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Genomictree Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
G
|
Genomictree Inc
KOSDAQ:228760
|
251.4B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
450.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
206.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
179.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
80B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
54.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
46.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
43.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Genomictree Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Genomictree Inc has total debt of 18m KRW. This includes both short-term (0 KRW) and long-term (18m KRW) debt.
You can find a full breakdown on its Balance Sheet.